BridgeMD
New treatment option for Cardiovascular Diseases
Official title Effects of Exergaming to Reduce Sedentary Time in Inactive Patients With Heart Failure
ClinicalTrials.gov ID: NCT05641662
What this study is testing
- What it's testing
- The goal of this to determine the effect of tailored exergaming for inactive patients with heart failure to reduce their sedentary time, improve their daily physical activity, exercise capacity, decrease frailty and improve health-related quality of life. Participants will, on a background of standard guideline-directed medical therapy patients, be randomised to tailored activity advice (control) or the Heart-Exergame (Heart-eXg) intervention for a period of 3 months.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Diagnosed with symptomatic HF (NYHA II-IV) as diagnosed by cardiologist, (independent of Ejection Fraction: Patients with a preserved ejection...
- Clinically stable
- Physically inactive
- Older than 18 years, there is no upper age limit,
- Speak/understand the language of the country where the study is taking place.
You likely can't join if
- Unable to use an exergame due to visual, hearing, cognitive impairment assessed by HF nurse or cardiologist.
- Not being able to perform the 6-minute walk test.
- Not being able or willing to wear an activity monitor.
- Currently included in a rehabilitation program
- Lack of willingness to play an exergame.
- Co-morbidity that hinders benefitting for this form of exercise (history of stroke, severe cognitive dysfunction, or a life expectancy shorter than 6...
See the full eligibility criteria
- Diagnosed with symptomatic HF (NYHA II-IV) as diagnosed by cardiologist, (independent of Ejection Fraction: Patients with a preserved ejection fraction (HFpEF), mid-range ejection fraction (HFmrREF) or reduced ejection...
- Clinically stable
- Physically inactive
- Older than 18 years, there is no upper age limit,
- Speak/understand the language of the country where the study is taking place.
- Wanting to use a smartphone for the study (if patients do not have a smartphone, they can borrow it from the study team for the duration of the study)
- Unable to use an exergame due to visual, hearing, cognitive impairment assessed by HF nurse or cardiologist.
- Not being able to perform the 6-minute walk test.
- Not being able or willing to wear an activity monitor.
- Currently included in a rehabilitation program
- Lack of willingness to play an exergame.
- Co-morbidity that hinders benefitting for this form of exercise (history of stroke, severe cognitive dysfunction, or a life expectancy shorter than 6 months).
The study team makes the final eligibility decision.
Where it's taking place
- Porto, Portugal
- Košice, Slovakia
- Barcelona, Spain
- Manresa, Spain
- Valencia, Spain
- Jönköping, Sweden
- Kalmar, Sweden
- Linköping, Sweden
- Norrköping, Sweden
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Porto, Portugal; Košice, Slovakia; Barcelona, Spain; Manresa, Spain; Valencia, Spain; Jönköping, Sweden and 3 more location(s). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.